[Pharmaco-clinical and therapeutic study of a new anthelmintic, or Mebendazole (R 17,635), in polyparasitized children].
D000284:Administration, Oral; D000293:Adolescent; D000367:Age Factors; D000871:Anthelmintics / Q000009:adverse effects / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D001565:Benzoates / Q000009:adverse effects / Q000627:therapeutic use; D002219:Carbamates / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005069:Evaluation Studies as Topic; D005260:Female; D006373:Helminthiasis / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male
D000871:Anthelmintics; D001562:Benzimidazoles; D001565:Benzoates; D002219:Carbamates
Estudo farmacoclínico e terapêutico de um novo anti-helmíntico, o Mebendazole (R 17.635), em crianças poliparasitadas.